Status:
COMPLETED
Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia
Lead Sponsor:
Aalborg University Hospital
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Despite improved treatment, cardiovascular disease remains one of the most common diseases and causes of death in the Western world. Hypercholesterolemia is a well known risk factor for developing car...
Eligibility Criteria
Inclusion
- BMI 18,5 - 35 kg/m2
- LDL cholesterol \> 3,5 mmol/l
Exclusion
- Triglycerides \> 5,0 mmol/l
- Use of phytosterols, food supplements containing soy protein or water soluble fiber supplements
- Cardiovascular disease
- Diabetes mellitus
- Gastrointestinal disease
- Liver- og kidney disease
- Electrolyte imbalance
- Orlistat treatment
- Alcohol abuse
- Hypersensitivity to the interventional substances
- Pregnancy and nursing
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01251991
Start Date
January 1 2011
End Date
January 1 2012
Last Update
January 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Lipid Clinic, Aalborg Hospital
Aalborg, RN, Denmark, 9000